Brainstorm Cell Therapeutics, Inc. (BCLI)
1.03
+0.03
(+3.00%)
USD |
OTCM |
Sep 10, 16:00
Brainstorm Cell Therapeutics Gross Profit (TTM) : -0.179M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.179M |
| March 31, 2026 | -0.184M |
| December 31, 2025 | -0.199M |
| September 30, 2025 | -0.204M |
| June 30, 2025 | -0.215M |
| March 31, 2025 | -0.228M |
| December 31, 2024 | -0.24M |
| September 30, 2024 | -0.253M |
| June 30, 2024 | -0.259M |
| March 31, 2024 | -0.262M |
| December 31, 2023 | -0.265M |
| September 30, 2023 | -0.269M |
| June 30, 2023 | -0.274M |
| March 31, 2023 | -0.278M |
| December 31, 2022 | -0.285M |
| September 30, 2022 | -0.285M |
| June 30, 2022 | -0.282M |
| March 31, 2022 | -0.273M |
| December 31, 2021 | -0.26M |
| September 30, 2021 | -0.254M |
| June 30, 2021 | -0.243M |
| March 31, 2021 | -0.231M |
| December 31, 2020 | -0.219M |
| September 30, 2020 | -0.205M |
| June 30, 2020 | -0.186M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.169M |
| December 31, 2019 | -0.164M |
| September 30, 2019 | -0.135M |
| June 30, 2019 | -0.131M |
| March 31, 2019 | -0.129M |
| December 31, 2018 | -0.11M |
| September 30, 2018 | -0.117M |
| June 30, 2018 | -0.107M |
| March 31, 2018 | -0.094M |
| December 31, 2017 | -0.085M |
| September 30, 2017 | -0.079M |
| June 30, 2017 | -0.073M |
| March 31, 2017 | -0.077M |
| December 31, 2016 | -0.077M |
| September 30, 2016 | -0.069M |
| June 30, 2016 | -0.078M |
| March 31, 2016 | -0.08M |
| December 31, 2015 | -0.087M |
| September 30, 2015 | -0.099M |
| June 30, 2015 | -0.103M |
| March 31, 2015 | -0.104M |
| December 31, 2014 | -0.106M |
| September 30, 2014 | -0.10M |
| June 30, 2014 | -0.097M |
| March 31, 2014 | -0.089M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| NovelStem International Corp. | 0.00 |
| Summit Therapeutics, Inc. | -0.174M |
| Kezar Life Sciences, Inc. | -0.693M |
| Protara Therapeutics, Inc. | -0.343M |
| Clene, Inc. | -1.295M |